ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Ovarian Cancer

Breast Cancer trials near San Diego, CA, USA:

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. (BRIA-ABC)

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

San Diego, California, United States and 48 other locations

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

San Diego, California, United States and 8 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Diego, California, United States and 226 other locations

Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...

Enrolling
Breast Cancer
Breast Carcinoma in Situ
Other: Screening advice based on a basic risk assessment
Other: Complete a health questionnaire
University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Diego, California, United States and 10 other locations

This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer...

Enrolling
Advanced Breast Cancer
Drug: Elacestrant
Drug: MEN2312

Phase 1

Stemline Therapeutics
Stemline Therapeutics

La Jolla, California, United States and 19 other locations

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer...

Active, not recruiting
Breast Cancer
Device: Radiofrequency Ablation
University of Arkansas
University of Arkansas

San Diego, California, United States and 5 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Encinitas, California, United States and 446 other locations

oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...

Active, not recruiting
Breast Cancer
Renal Cell Carcinoma
Drug: nab-paclitaxel
Drug: Bevacizumab

Phase 2

Infinity Pharmaceuticals
Infinity Pharmaceuticals

San Diego, California, United States and 23 other locations

OKI-219-101 is a Phase 1a/1b, open-label, multicenter, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), ph...

Enrolling
Advanced Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Fulvestrant

Phase 1

OnKure

La Jolla, California, United States and 30 other locations

This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unre ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab deruxtecan (T-DXd)
Drug: Ado-trastuzumab emtansine (T-DM1)

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Diego, California, United States and 163 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems